Regulatory Reform Omnibus Act 2025 (73 of 2025)

Schedule 2   Amendments to improve or maintain access to government services

Part 4   Strengthening integrity of the pharmacy approval process

Division 1   Main amendments

National Health Act 1953

31   After paragraph 98(3)(b)

Add:

or (c) an approved pharmacist's registration as a pharmacist or pharmaceutical chemist under a law of a State or Territory providing for the registration of pharmacists or pharmaceutical chemists has been suspended (however described); or

(d) an approved pharmacist has been deregistered (however described) as a pharmacist or pharmaceutical chemist under a law of a State or Territory providing for the registration of pharmacists or pharmaceutical chemists; or

(e) if an approved pharmacist is a body corporate:

(i) a person who is a director of the body corporate has been suspended or deregistered (however described) as a pharmacist or pharmaceutical chemist under a law of a State or Territory providing for the registration of pharmacists or pharmaceutical chemists; and

(ii) there is no other director of the body corporate who is registered (however described) as a pharmacist or pharmaceutical chemist under a law of a State or Territory providing for the registration of pharmacists or pharmaceutical chemists; or

(f) if an approved pharmacist is granted approval to supply pharmaceutical benefits at a particular premises in a State or territory - the approved pharmacist is not permitted, under the law of the State or Territory in which the premises are situated, to carry on business; or

(g) an approved pharmacist has breached the conditions to which the pharmacist's approval is subject;